Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor
- 13 June 2005
- journal article
- Published by Elsevier in Acta Biomaterialia
- Vol. 1 (4) , 451-459
- https://doi.org/10.1016/j.actbio.2005.04.004
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineeringNature Biotechnology, 2005
- Modulation of Angiogenic Potential of Collagen Matrices by Covalent Incorporation of Heparin and Loading with Vascular Endothelial Growth FactorTissue Engineering, 2004
- Facile Solid-Phase Synthesis of Sulfated Tyrosine-Containing Peptides: Total Synthesis of Human Big Gastrin-II and Cholecystokinin (CCK)-391,2The Journal of Organic Chemistry, 2000
- Cutaneous Wound HealingNew England Journal of Medicine, 1999
- Polypeptide growth factors: targeted delivery systemsBiomaterials, 1997
- The Carboxyl-terminal Domain(111–165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic PotencyJournal of Biological Chemistry, 1996
- Heparin Structure and Interactions with Basic Fibroblast Growth FactorScience, 1996
- Variations in the Size and Sulfation of Heparin Modulate the Effect of Heparin on the Binding of VEGF165 to Its ReceptorsBiochemical and Biophysical Research Communications, 1994
- Energetic Characterization of the Basic Fibroblast Growth Factor-Heparin Interaction: Identification of the Heparin Binding DomainBiochemistry, 1994
- Evaluation of the Final Deprotection System for the Solid-Phase Synthesis of Tyr(SO3H)-Containing Peptides with 9-Fluorenylmethyloxycarbonyl (Fmoc)-Strategy and Its Application to the Synthesis of Cholecystokinin (CCK)-12.CHEMICAL & PHARMACEUTICAL BULLETIN, 1993